Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticlePhysics/Instrumentation

Hybrid Surgical Guidance: Does Hardware Integration of γ- and Fluorescence Imaging Modalities Make Sense?

Gijs H. KleinJan, Daan Hellingman, Nynke S. van den Berg, Matthias N. van Oosterom, Kees Hendricksen, Simon Horenblas, Renato A. Valdes Olmos and Fijs WB van Leeuwen
Journal of Nuclear Medicine April 2017, 58 (4) 646-650; DOI: https://doi.org/10.2967/jnumed.116.177154
Gijs H. KleinJan
1Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands
2Department of Nuclear Medicine, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daan Hellingman
2Department of Nuclear Medicine, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
3Oncovision (GEM Imaging S.A.), Centro de Investigación Príncipe Felipe, Valencia, Spain; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nynke S. van den Berg
1Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands
4Department of Urology, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias N. van Oosterom
1Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kees Hendricksen
4Department of Urology, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Horenblas
4Department of Urology, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renato A. Valdes Olmos
1Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands
2Department of Nuclear Medicine, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fijs WB van Leeuwen
1Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands
4Department of Urology, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Schematic overview of VITOM-GP and VITOM-GC combination. (A) VITOM-GP combination. (B) VITOM-GC combination. Because of angle in alignment, devices had to be moved horizontally to compensate for misalignment at distances beyond focal plane.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Fluorescence imaging versus γ-detection. On left side, SN detection rates (%) of VITOM-GP combination are shown in relation to the evaluated working distances (A–F). On right, SN detection rates (%) of VITOM-GC are presented in relation to the different evaluated working distances (G–L).

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1

    Patient Characteristics

    Patient no.Clinical TNM stageInjected dose (MBq)No. of SNs on SPECT/CTNo. of pursued SNsNo. of groinsNo. of SNs at pathologyNo. of tumor-positive SNs
    Patients evaluated with VITOM-GP
     1cT2N0Mx184.2843 (75%)130
     2cT3N0Mx77.8721 (50%)150
     3cT3N0Mx162.7423 (100%)*130
     4cT3N0Mx8421 (50%)130
     5cT2N0Mx83.6941 (25%)141
    Total1495181
    Patients evaluated with VITOM-GC
     1cT3N0M0143.2332 (67%)131
     2cT1N0Mx145.3711 (100%)110
     3cT1bN0Mx144.6622 (100%)220
     4cT2N0M071.6222 (100%)240
     5cT2N0M070.3722 (100%)220
     6cT1/2N0Mx87.5151 (20%)170
    Total15109191
    • ↵* Intraoperative additional SN removed.

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 58 (4)
Journal of Nuclear Medicine
Vol. 58, Issue 4
April 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hybrid Surgical Guidance: Does Hardware Integration of γ- and Fluorescence Imaging Modalities Make Sense?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Hybrid Surgical Guidance: Does Hardware Integration of γ- and Fluorescence Imaging Modalities Make Sense?
Gijs H. KleinJan, Daan Hellingman, Nynke S. van den Berg, Matthias N. van Oosterom, Kees Hendricksen, Simon Horenblas, Renato A. Valdes Olmos, Fijs WB van Leeuwen
Journal of Nuclear Medicine Apr 2017, 58 (4) 646-650; DOI: 10.2967/jnumed.116.177154

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Hybrid Surgical Guidance: Does Hardware Integration of γ- and Fluorescence Imaging Modalities Make Sense?
Gijs H. KleinJan, Daan Hellingman, Nynke S. van den Berg, Matthias N. van Oosterom, Kees Hendricksen, Simon Horenblas, Renato A. Valdes Olmos, Fijs WB van Leeuwen
Journal of Nuclear Medicine Apr 2017, 58 (4) 646-650; DOI: 10.2967/jnumed.116.177154
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Synthesis of Patient-Specific Transmission Data for PET Attenuation Correction for PET/MRI Neuroimaging Using a Convolutional Neural Network
  • Dynamic 18F-FDG PET Lymphography for In Vivo Identification of Lymph Node Metastases in Murine Melanoma
  • Google Scholar

More in this TOC Section

  • Zero-Echo-Time and Dixon Deep Pseudo-CT (ZeDD CT): Direct Generation of Pseudo-CT Images for Pelvic PET/MRI Attenuation Correction Using Deep Convolutional Neural Networks with Multiparametric MRI
  • Comparison of PET/CT with Sequential PET/MRI Using an MR-Compatible Mobile PET System
  • PET Imaging Stability Measurements During Simultaneous Pulsing of Aggressive MR Sequences on the SIGNA PET/MR System
Show more Physics/Instrumentation

Similar Articles

Keywords

  • Fluorescence guidance
  • Radioguidance
  • Hybrid modality
  • sentinel node biopsy
  • image-guided surgery
SNMMI

© 2025 SNMMI

Powered by HighWire